Stop Watching the Market. Take a Seat at the Table – China & Russia Session at BIOCHINA 2026
Details
BIOCHINA 2026 Surpasses 10,000 Registrations – Secure Your Spot Now
2025: A Breakout Year for China’s Innovative Drug Industry
$570M Deal: MediLink Therapeutics Licenses YL201 B7H3 ADC to Roche
China–Australia Biotech Collaboration Session at BIOCHINA2026
Antibody Therapeutics Set to Transform Global Biopharma: BIOCHINA 2026 Highlights Innovation and Development Strategies
679 C-Level Executives Are Already On Board for BIOCHINA2026
BIOCHINA2026 Update: Oligonucleotide Drug Innovation & Development Forum to Spotlight China’s Next Growth Engine
Biopharma 2025: The Evolution of NewCo and Multi-Dimensional Collaboration of Chinese Innovative Drug Companies
Stem Cell Forum Schedule & Speaker Lineup Announced at BIOCHINA2026
